Clinical trial

Immunotherapy With TG4010 in Patients With Advanced Non-Small Cell Lung Cancer

NCT00415818

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-12-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2005-12-01Date precision: month

Registry last updated2014-07-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Carcinoma, Non-Small-Cell Lungunresolved

Interventions

MVA-MUC1-IL2BIOLOGICAL

1st line ChemotherapyDRUG

Sponsors & collaborators

Transgenelead sponsor

Mapped research locations

MarseilleFrance1 StrasbourgFrance1 LilleFrance1 KrakowPoland1 PoznanPoland1 RennesFrance1 WroclawPoland1 BialystokPoland1 CaenFrance1 HeidelbergGermany1 CologneGermany1 BydgoszczPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00415818 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.